Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia. Hivert B, Caron C, Petit S, Charpy C, Fankam-Siaka C, Lecocq S, Zawadzki C, Susen S, Rusu M, Duhamel A, Tournilhac O, Goudemand J, & Morel P Blood, 120:3214-3221, 2012.
Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia [link]Paper  doi  bibtex   
@article{hivert_b_clinical_2012,
title = {Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia},
volume = {120},
issn = {0006-4971},
url = {http://www.ncbi.nlm.nih.gov/pubmed/22896002},
DOI = {10.1182/blood-2011-11-388256},
Language = {English},
Journal = {Blood},
author = {{Hivert B} and {Caron C} and {Petit S} and {Charpy C} and {Fankam-Siaka C} and {Lecocq S} and {Zawadzki C} and {Susen S} and {Rusu M} and {Duhamel A} and {Tournilhac O} and {Goudemand J} and {Morel P}},
year = {2012},
keywords = {Adult, Aged, Biomarkers, Tumor/metabolism*, Blood Viscosity, Female, Humans, Immunoglobulin M/metabolism*, Male, Microvessels/pathology, Middle Aged, Prognosis, Vascular Endothelial Growth Factor A/metabolism, Waldenstrom Macroglobulinemia/diagnosis*, Waldenstrom Macroglobulinemia/metabolism, von Willebrand Factor/metabolism*},
pages = {3214-3221}
}

Downloads: 0